Bax:Bcl2 Cancer Research Results
Bax:Bcl2, Bax:Bcl2 ratio: Click to Expand ⟱
| Source: |
| Type: |
Bax and Bcl-2 are the major members of Bcl-2 family that play a key role in tumor progression or inhibition of intrinsic apoptotic pathway triggered by mitochondrial dysfunction.
Bax/Bcl-2 ratio is typically significantly lower in tumors.
|
NA, Not Available: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
Pca, |
22Rv1 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
TumCCA↑, Apoptosis↑, HDAC↓, P21↑, BAX↑, TumCG↓, Bcl-2↓, Bax:Bcl2↑, HDAC1↓, HDAC3↓,
angioG↓, EMT↓, CSCs↓, TumCCA↑, Dose∅, ROS↑, MMP↓, Catalase↓, GSH↓, PI3K↓, Akt↓, NF-kB↓, OCT4↓, Nanog↓, SIRT3↓, SIRT6↓, eff↑, eff↑, Cyt‑c↑, Bax:Bcl2↑, p‑GSK‐3β↓, FOXO3↑, p‑STAT3↓, MMP2↓, MMP9↓, COX2↓, MMPs↓, NRF2↓, HDAC↓, Telomerase↓, eff↑, eff↑, eff↑, eff↑, eff↑, XIAP↓, survivin↓, CK2↓, HSP90↓, Hif1a↓, FAK↓, EMT↓,
Bax:Bcl2↑, P53↑, ROS↑, Casp9↑, Casp8↑, cl‑PARP1↑, p‑ERK⇅, p‑JNK↓, p‑p38↑, p‑Akt↓, cJun↓, NF-kB↓, EGFR↓, TumCCA↑,
TumCCA↑, TP53↑, COX2↓, Bax:Bcl2↑, ROS↑, VEGFR2↓, Akt↓, ERK↓, MMP2↓, MMP9↓, IL8↑, P21↑, p27↑, E-cadherin↓, Fibronectin↓, cMyc↓,
| - |
in-vitro, |
CRC, |
LS1034 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
tumCV↓, TumCCA↑, ROS↑, Ca+2↑, MMP↓, Apoptosis↑, Cyt‑c↑, Casp9↑, Bax:Bcl2↑,
tumCV↓, Casp3↑, Casp9↑, MMP↓, Cyt‑c↑, BAX↑, Bax:Bcl2↑,
GlucoseCon↓, ATP↓, HIF-1↓, GLUT1↓, GLUT4↓, HK2↓, LDHA↓, ERK↓, Akt↓, Apoptosis↑, NF-kB↓, ROS↑, Bax:Bcl2↑, MMP↓, Casp3↑, Casp9↑, p‑JNK↓,
*PI3K↑, *Akt↑, p‑Akt↓, SIRT3↑, p‑ERK↓, p38↓, VEGF↓, MEK↓, MKK4↓, MMP9↓, Raf↓, F-actin↓, MMP2↓, COX2↓, BMP2↓, cycD1/CCND1↓, Bax:Bcl2↑, EMT↓, EGFR↓, TumAuto↑,
Showing Research Papers: 1 to 8 of 8
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 8
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
Catalase↓, 1, GSH↓, 1, NRF2↓, 1, ROS↑, 5, SIRT3↓, 1, SIRT3↑, 1,
Mitochondria & Bioenergetics ⓘ
ATP↓, 1, MEK↓, 1, MKK4↓, 1, MMP↓, 4, Raf↓, 1, XIAP↓, 1,
Core Metabolism/Glycolysis ⓘ
cMyc↓, 1, GlucoseCon↓, 1, HK2↓, 1, LDHA↓, 1,
Cell Death ⓘ
Akt↓, 3, p‑Akt↓, 2, Apoptosis↑, 3, BAX↑, 2, Bax:Bcl2↑, 8, Bcl-2↓, 1, BMP2↓, 1, Casp3↑, 2, Casp8↑, 1, Casp9↑, 4, CK2↓, 1, Cyt‑c↑, 3, p‑JNK↓, 2, p27↑, 1, p38↓, 1, p‑p38↑, 1, survivin↓, 1, Telomerase↓, 1,
Transcription & Epigenetics ⓘ
cJun↓, 1, tumCV↓, 2,
Protein Folding & ER Stress ⓘ
HSP90↓, 1,
Autophagy & Lysosomes ⓘ
TumAuto↑, 1,
DNA Damage & Repair ⓘ
P53↑, 1, cl‑PARP1↑, 1, SIRT6↓, 1, TP53↑, 1,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 1, P21↑, 2, TumCCA↑, 5,
Proliferation, Differentiation & Cell State ⓘ
CSCs↓, 1, EMT↓, 3, ERK↓, 2, p‑ERK↓, 1, p‑ERK⇅, 1, FOXO3↑, 1, p‑GSK‐3β↓, 1, HDAC↓, 2, HDAC1↓, 1, HDAC3↓, 1, Nanog↓, 1, OCT4↓, 1, PI3K↓, 1, p‑STAT3↓, 1, TumCG↓, 1,
Migration ⓘ
Ca+2↑, 1, E-cadherin↓, 1, F-actin↓, 1, FAK↓, 1, Fibronectin↓, 1, MMP2↓, 3, MMP9↓, 3, MMPs↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, EGFR↓, 2, HIF-1↓, 1, Hif1a↓, 1, VEGF↓, 1, VEGFR2↓, 1,
Barriers & Transport ⓘ
GLUT1↓, 1, GLUT4↓, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 3, IL8↑, 1, NF-kB↓, 3,
Drug Metabolism & Resistance ⓘ
Dose∅, 1, eff↑, 7,
Clinical Biomarkers ⓘ
EGFR↓, 2, TP53↑, 1,
Total Targets: 83
Pathway results for Effect on Normal Cells:
Cell Death ⓘ
Akt↑, 1,
Proliferation, Differentiation & Cell State ⓘ
PI3K↑, 1,
Total Targets: 2
Scientific Paper Hit Count for: Bax:Bcl2, Bax:Bcl2 ratio
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:0 Cells:% prod#:% Target#:352 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page